ST. PAUL, Minn., February 21, 2013 – For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence… read more →
On the regular “Health Smart” segment on television station KTLA.com, anchors discuss the benefits of the LINX System for patients with chronic Acid Reflux, oftentimes referred to as Heartburn.
FDA Approves LINX® System for the Treatment of Reflux Disease ST. PAUL, MINNESOTA – March 27, 2012 – Torax Medical today announced that the U.S. Food and Drug Administration (FDA)… read more →
The New England Journal of Medicine Publishes Clinical Study of Minimally-Invasive Device for Treatment of Reflux Disease ST. PAUL, Minn., February 21, 2013 – For the millions who suffer from… read more →
powered by Malladi Bariatrics and Advanced Surgery.
The fundamental pathologic abnormality in gastroesophageal reflux disease is an incompetent lower esophageal sphincter.– First-line therapy for gastroesophageal reflux disease is acid suppression, usually with proton-pump inhibitors. Although effective, proton-pump inhibitors provide incomplete…
The post Esophageal Sphincter Device for Gastroesophageal Reflux Disease appeared first on Linx Reflux Center of Dallas.